Under this agreement Apollo Healthcare will provide its Prior-Authorization package, amongst other services to ART’s existing customer base, as well as any healthcare facilities considering use of their products such as PreciseRT and AccuBoost for adoption within their clinical patient treatment armamentariums.

October 21, 2021 — Advanced Radiation Therapy, LLC (ART) and Apollo Healthcare have announced a strategic partnership aimed at easing the challenge radiation oncology clinics have in pre-authorizing patients for insurance coverage for innovative radiation cancer therapies. Under this agreement Apollo Healthcare will provide its Prior-Authorization package, amongst other services to ART’s existing customer base, as well as any healthcare facilities considering use of their products such as PreciseRT and AccuBoost for adoption within their clinical patient treatment armamentariums. 

“We are very excited to be teaming with Apollo Healthcare to ensure oncology patients that can benefit from PreciseRT and AccuBoost are able to receive our novel Non-Invasive Breast Brachytherapy (NIBB) treatments with no delay or interruption to care based on insurance coverage.” remarked Bill Dowd, Chief Executive Officer of Advanced Radiation Therapy, LLC.

By leveraging the human resources, financial modeling and intimate knowledge of commercial and Medicare insurance coding and payment coverage provided by Apollo Healthcare a U.S. based healthcare facility can be sure that physicians will be able to treat patients with the technology of their choice and that the health care facility will be paid the appropriate payment for the lifesaving care the center provides each cancer patient. 

“Apollo Healthcare is ready to serve as an additional resource to clinics utilizing ART’s products and technology. We are a team of experienced oncology administrative and clinical veterans who relish the opportunity to wade through the details to get to the core problem of preauthorization delays and payment denials ensuring that physicians can utilize the best technology for their patients’ needs and the health care facilities in which they practice will equitably be paid for the care they deliver,” Christopher Gonzalez, Co-founder of Apollo commented. ART will be showcasing this new partnership at the upcoming American Society of Therapeutic Radiation Oncologists (ASTRO) annual meeting in Chicago, Illinois from October 24-27. 2021.

For more information: www.apollohealthcare.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
Feature | Computed Tomography (CT) | By Melinda Taschetta-Millane

In the ever-evolving landscape of medical imaging, computed tomography (CT) stands out as a cornerstone technology ...

Time July 30, 2024
arrow
News | Breast Imaging

July 29, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...

Time July 29, 2024
arrow
News | Artificial Intelligence

July 26, 2024 — GE HealthCare and Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company, announced a strategic ...

Time July 26, 2024
arrow
Feature | Mobile C-Arms | By Melinda Taschetta-Millane

Mobile C-arms continue to revolutionize medical imaging, offering versatility, mobility and real-time visualization ...

Time July 26, 2024
arrow
Videos | Information Technology

Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and ...

Time July 25, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
Subscribe Now